76 participants
A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-09
- Start Date:
- 2025-06-04
- Completion:
- 2029-04-30
Conditions
- Large B-cell Lymphoma
Interventions
- DRUG
No Results Yet